Pilot Study of RR-HNK in OCD

NCT06575075 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Obsessive-Compulsive Disorder

Interventions

DRUG: RR-HNK/Hydroxynorketamine
DRUG: Placebo

Sponsor

Carolyn Rodriguez

Collaborators

[object Object]